Document is current
Any future updates will be listed below
-
Authors
Garay, Joseph P.
Smith, Rebecca
Devlin, Kaylyn
Hollern, Daniel P.
Liby, Tiera
Liu, Moqing
Boddapati, Shanta
Watson, Spencer S.
Esch, Amanda
Zheng, Ting
Thompson, Wallace
Babcock, Darcie
Kwon, Sunjong
Chin, Koei
Heiser, Laura
Gray, Joe W.
Korkola, James E. https://orcid.org/0000-0002-0030-6216
-
Funding
Funding for this research was provided by:
National Institutes of Health (HG008100, HG008100, HG008100)
National Cancer Institute (CA209988, CA209988, CA209988)
Susan G. Komen (SAC110012)
- License Information
-
More Information
Article History
Received: 7 March 2021
Accepted: 18 July 2021
First Online: 3 August 2021
Declarations
:
: All experiments were conducted under OHSU-approved protocols. No IRB or IACUC approval was required as no studies were conducted using identifiable patient samples or in animals.
: Not applicable
: J.W.G. receives research support from Zeiss, Micron, Miltenyi, and Thermo Fisher; he has licensed relevant diagnostic technologies to Abbott Diagnostics and holds stock in Abbott Diagnostics, General Electric, Amgen, and Gilead; he has ownership positions in Convergent Genomics and PDX Pharmaceuticals; and he serves as a paid consultant to New Leaf Ventures.
